Detection of tyrosinase mRNA in tumor tissue microdissections from classic Kaposi's sarcoma by Palmieri, G. et al.
Annuls of Oncology 12: 1765-1766,2001.
Letters to the editor
Gastrointestinal metastases in
lobular breast cancer
In a previous issue of Annals of Oncology, Bamias et al. re-
ported the clinical case of a patient with rectal metastasis from
lobular carcinoma of the breast (ILC) [1], In their summary of
the literature, our series of 17 patients with colorectal metas-
tases reported in 1992 is mentioned [2], However, five of the_
seven patients with rectal localisation selected for their table,
suffered from additional infiltration of parts of the colon. In
only two cases the rectum was the sole localisation of meta-
static gastrointestinal involvement. We would like to add some
more information on this subject to put it into perspective.
One patient (50 years) developed diarrhoea caused by rectal
stenosis 15 months after the diagnosis of locally advanced,
lobular breast cancer. Endocrine treatment resulted in local
response until death due to cerebral metastases 22 months
later.
The second patient (51 years) had diarrhoea and weight loss
due to severe rectal obstruction, seven years after the treat-
ment of ILC . Anthracyclin based chemotherapy resulted in a
fair response of 9 months without the need for a colostomy.
She eventually died 11 months after the diagnosis of rectal
involvement due to diffuse peritoneal metastases.
Solitary rectal metastasis of breast cancer is a rare condi-
tion. In contrast, gastric involvement is a more common event,
also prefentially occurring in ILC [3]. In our series 36 of 51
patients with gastric metastases had ILC [4]. Endoscopy
showed mainly a diffuse linitis plastica-hke infiltration (57%),
but also localised lesions (18%) such as ulceration and a
polypoid mass, or stenosis due to extrinsic compression at the
cardiac junction or the pylorus (25%) were present. Symptoms
were non-specific: anorexia (71%), epigastric pain (53%) and
vomiting (41%). The interval between primary breast cancer
and intestinal complaints was prolonged (median 62 months,
range 2-104). Metastases at other sites were present in 48 of 51
patients. The presenting site of metastatic disease was: skeleton
(43%), stomach (27%), lung (8%) and liver (4%). The overall
response to systemic therapy was fairly good with 46% despite
the pre-treatment in half of the patients. Calculated from the
detection of gastric metastases the median survival was 11
months with some long-term survivors leading to a two-year
survival of 23%.
Based on tumour invasion primarily in the subserosa, it not
surprising that the endoscopic biopsies might be negative. In
our series of gastric metastases endoscopic biopsies were
positive in 35 patients; in six cases a second endoscopy re-
vealed tumour cells, while in 10 patients with a negative
histology the diagnosis was based on circumstantial evidence
from the characteristic endoscopic features along with metas-
tases at other sites. Also, in the case of Bamias et al. repeated
biopsies were helpful [1].
In conclusion: especially in lobular type of breast cancer
metastases in the gastrointestinal tract occur, often with
metastases at other sites as the skeleton. Gastric metastases
occur more frequently than colorectal metastases.
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Detection of tyrosinase mRNA in
tumor tissue microdissections from
classic Kaposi's sarcoma
Classic Kaposi's sarcoma (CKS) is a systemic, multifocal,
angiomatous, rare tumor [1], CKS is more common in the
Mediterranean area (mostly, in people of Italian and Greek
origin), with the highest incidence found among Jews in Israel
[2]. Although Kaposi's sarcoma-associated herpesvirus (KSHV
or human herpesvirus 8) has been causally linked to CKS, the
factors involved in the tumorigenesis and prognosis of the
disease are still unidentified [1]. In addition, very little is known
about the molecular mechanisms underlying the prevalence of
clinical and pathological correlation between CKS and malig-
nant melanoma (MM) [2]. In our previous study, circulating
melanoma-associated (MA) markers were detected in peripheral
blood of CKS patients by reverse transcriptase-polymerase
chain reaction (RT-PCR) [3], Briefly, 13 (62%) out of 21 CKS
patients were found positive to at least one of the two most
specific MA markers used in that study [in particular, 3 of 21
(14%) and 11 of 21 (52%) were found positive to tyrosinase and
MelanA/Martl markers, respectively] [3]. To evaluate whether
presence of MA markers in peripheral blood of CKS patients
could be due to abnormal expression of such mRNAs in CKS
tumor cells, we performed a RT-PCR analysis on a subset of
microdissected tumor tissues from CKS patients.
Histological samples were selected from 16 patients with
ascertained diagnosis of CKS (archival stained slides were
further evaluated in order to confirm previous diagnosis and
better define the specific histological type). Serial 4-um sections
were cut from formalin-fixed, paraffin-embedded-tissues and
slides were stained with methyl green before laser capture
microdissection using a PixCell laser capture microscope
(Arcturus Engineering, Mountain View, California) as pre-
viously described [4], Total cellular RNA was isolated and
subsequently amplified by RT-PCR with primers specific for
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tyrosinase and MelanA/Marti markers following our reported
experimental protocols [5].
Amplification of GAPDH mRNA (a housekeeping gene
product as positive control) gave no PCR product in six tumor
samples of our series. Figure 1 shows RT-PCR results in the
remaining 10 CKS tissues with expression of GAPDH mRNA.
Specific amplification for individual MA markers was only
observed for tyrosinase in cases 2, 10, and 12 of our series (as
also confirmed by Southern blot hybridization) (Figure 1).
For eight of such patients (cases 2, 3, 7, 9, 10. 12, 14, and 15 of
Tyrosinase
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Melan A / Marti
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- 1 2 8
Figure 1), peripheral blood sample was obtained (after a written
informed consent) and RT-PCR was performed. Tyrosinase
was detected in one CKS patient (case 2; 12.5%), whereas
MelanA/Martl marker was found in three blood samples
(cases 3, 7, and 9; 37.5%) (data not shown).
Considering the RT-PCR results on microdissected tumor
tissues, detection of tyrosinase in 3 of 10 (30%) samples and
absence of amplification for MelanA/Martl is a strong indica-
tion that these two markers present a different specificity as
melanoma-associated antigens. However, we found expression
of both MA mRNAs in peripheral blood of CKS patients (at
rates comparable to those we have previously reported [3]).
While positivity to tyrosinase in peripheral blood from CKS
patients seems to be due to the presence of metastatic tumor
cells expressing this MA marker, there is no explanation for the
detection of circulating MelanA/Martl. One could speculate
that in CKS patients cells of melanocytic lineage expressing
MelanA/Martl might be somehow induced to dissemination
and, thus, found in peripheral blood. Further improvements of
bio-technologies are awaited to systematically perform addi-
tional studies on large collections of CKS tumor tissues in
order to confirm our findings.
G. Palmieri,1 A. Cossu,2 A. Lissia,2 L. Leoncini,3
S. Lazzi,3 P. A. Ascierto,4 G. Castello4 & F.Tanda2*
^Institute of Molecular Genetics, C.N.R., Algliero; 2Insti-
tute of Pathology, University of Sassari; ^Institute of
Pathology, University of Siena; * Division of Clinical
Immunology, National Tumor Institute, Naples, Italy;
*Author for correspondence (e-mail: tandaf@ssmain.uniss.it)
M l 2 3 4 7 9 10 12 14 15 T N Nc
-160
Figure I RT-PCR results on microdissected tumor samples from CKS
patients. PCR products were separated by electrophoresis on a 2%
agarose gel and directly visualized by ethidium bromide staining. T -
human melanoma-derived cell line SK-MEL-29 as positive control.
N - PCR reagents and primers without RNA as reaction negative
control. Nc - RT reagents and random examers without RNA as
cDNA negative control: M - marker.
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